Pre-order Enquiry
Request Free Sample
Global Targeted Drug ROS1 Inhibitors for NSCLC Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
SKU ID : QYR-18541738 | Publishing Date : 14-Jun-2021 | No. of pages : 114
Detailed TOC of Global Targeted Drug ROS1 Inhibitors for NSCLC Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
1 Market Overview of Targeted Drug ROS1 Inhibitors for NSCLC1.1 Targeted Drug ROS1 Inhibitors for NSCLC Market Overview
1.1.1 Targeted Drug ROS1 Inhibitors for NSCLC Product Scope
1.1.2 Targeted Drug ROS1 Inhibitors for NSCLC Market Status and Outlook
1.2 Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Region (2016-2027)
1.4 Global Targeted Drug ROS1 Inhibitors for NSCLC Historic Market Size by Region (2016-2021)
1.5 Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size Forecast by Region (2022-2027)
1.6 Key Regions, Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027)
1.6.1 North America Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027)
1.6.2 Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027)
1.6.3 Asia-Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027)
1.6.4 Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027)
1.6.5 Middle East & Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027)
2 Targeted Drug ROS1 Inhibitors for NSCLC Market Overview by Type
2.1 Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global Targeted Drug ROS1 Inhibitors for NSCLC Historic Market Size by Type (2016-2021)
2.3 Global Targeted Drug ROS1 Inhibitors for NSCLC Forecasted Market Size by Type (2022-2027)
2.4 Crizotinib
2.5 Lorlatinib
2.6 Entrectinib
2.7 Other
3 Targeted Drug ROS1 Inhibitors for NSCLC Market Overview by Application
3.1 Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global Targeted Drug ROS1 Inhibitors for NSCLC Historic Market Size by Application (2016-2021)
3.3 Global Targeted Drug ROS1 Inhibitors for NSCLC Forecasted Market Size by Application (2022-2027)
3.4 Squamous Cell Carcinoma of NSCLC
3.5 Adenocarcinoma of NSCLC
3.6 Large Cell Carcinoma of NSCLC
4 Targeted Drug ROS1 Inhibitors for NSCLC Competition Analysis by Players
4.1 Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Targeted Drug ROS1 Inhibitors for NSCLC as of 2020)
4.3 Date of Key Players Enter into Targeted Drug ROS1 Inhibitors for NSCLC Market
4.4 Global Top Players Targeted Drug ROS1 Inhibitors for NSCLC Headquarters and Area Served
4.5 Key Players Targeted Drug ROS1 Inhibitors for NSCLC Product Solution and Service
4.6 Competitive Status
4.6.1 Targeted Drug ROS1 Inhibitors for NSCLC Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Roche
5.1.1 Roche Profile
5.1.2 Roche Main Business
5.1.3 Roche Targeted Drug ROS1 Inhibitors for NSCLC Products, Services and Solutions
5.1.4 Roche Targeted Drug ROS1 Inhibitors for NSCLC Revenue (US$ Million) & (2016-2021)
5.1.5 Roche Recent Developments
5.2 Pfizer
5.2.1 Pfizer Profile
5.2.2 Pfizer Main Business
5.2.3 Pfizer Targeted Drug ROS1 Inhibitors for NSCLC Products, Services and Solutions
5.2.4 Pfizer Targeted Drug ROS1 Inhibitors for NSCLC Revenue (US$ Million) & (2016-2021)
5.2.5 Pfizer Recent Developments
5.3 Beacon Pharma Limited
5.5.1 Beacon Pharma Limited Profile
5.3.2 Beacon Pharma Limited Main Business
5.3.3 Beacon Pharma Limited Targeted Drug ROS1 Inhibitors for NSCLC Products, Services and Solutions
5.3.4 Beacon Pharma Limited Targeted Drug ROS1 Inhibitors for NSCLC Revenue (US$ Million) & (2016-2021)
5.3.5 Drug International Limted Recent Developments
5.4 Drug International Limted
5.4.1 Drug International Limted Profile
5.4.2 Drug International Limted Main Business
5.4.3 Drug International Limted Targeted Drug ROS1 Inhibitors for NSCLC Products, Services and Solutions
5.4.4 Drug International Limted Targeted Drug ROS1 Inhibitors for NSCLC Revenue (US$ Million) & (2016-2021)
5.4.5 Drug International Limted Recent Developments
5.5 Incepta Pharmaceuticals
5.5.1 Incepta Pharmaceuticals Profile
5.5.2 Incepta Pharmaceuticals Main Business
5.5.3 Incepta Pharmaceuticals Targeted Drug ROS1 Inhibitors for NSCLC Products, Services and Solutions
5.5.4 Incepta Pharmaceuticals Targeted Drug ROS1 Inhibitors for NSCLC Revenue (US$ Million) & (2016-2021)
5.5.5 Incepta Pharmaceuticals Recent Developments
...
6 North America
6.1 North America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2016-2027)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Targeted Drug ROS1 Inhibitors for NSCLC Market Dynamics
11.1 Targeted Drug ROS1 Inhibitors for NSCLC Industry Trends
11.2 Targeted Drug ROS1 Inhibitors for NSCLC Market Drivers
11.3 Targeted Drug ROS1 Inhibitors for NSCLC Market Challenges
11.4 Targeted Drug ROS1 Inhibitors for NSCLC Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Figures, Tables and Charts Available in Global Targeted Drug ROS1 Inhibitors for NSCLC Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
List of TablesTable 1. Global Market Targeted Drug ROS1 Inhibitors for NSCLC Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027
Table 2. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Region (2016-2021) & (US$ Million)
Table 3. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size Share by Region (2016-2021)
Table 4. Global Targeted Drug ROS1 Inhibitors for NSCLC Forecasted Market Size by Region (2022-2027) & (US$ Million)
Table 5. Global Targeted Drug ROS1 Inhibitors for NSCLC Forecasted Market Size Share by Region (2022-2027)
Table 6. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027
Table 7. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Type (2016-2021) & (US$ Million)
Table 8. Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue Market Share by Type (2016-2021)
Table 9. Global Targeted Drug ROS1 Inhibitors for NSCLC Forecasted Market Size by Type (2022-2027) & (US$ Million)
Table 10. Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue Market Share by Type (2022-2027)
Table 11. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027
Table 12. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Application (2016-2021) & (US$ Million)
Table 13. Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue Market Share by Application (2016-2021)
Table 14. Global Targeted Drug ROS1 Inhibitors for NSCLC Forecasted Market Size by Application (2022-2027) & (US$ Million)
Table 15. Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue Market Share by Application (2022-2027)
Table 16. Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue (US$ Million) by Players (2016-2021)
Table 17. Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue Market Share by Players (2016-2021)
Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Targeted Drug ROS1 Inhibitors for NSCLC as of 2020)
Table 19. Date of Key Manufacturers Enter into Targeted Drug ROS1 Inhibitors for NSCLC Market
Table 20. Global Targeted Drug ROS1 Inhibitors for NSCLC Top Players Headquarters and Area Served
Table 21. Targeted Drug ROS1 Inhibitors for NSCLC Product Solution and Service
Table 22. Global Targeted Drug ROS1 Inhibitors for NSCLC Players Market Concentration Ratio (CR5 and HHI)
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Roche Basic Information List
Table 25. Roche Description and Business Overview
Table 26. Roche Targeted Drug ROS1 Inhibitors for NSCLC Products, Services and Solutions
Table 27. Revenue (US$ Million) in Targeted Drug ROS1 Inhibitors for NSCLC Business of Roche (2016-2021)
Table 28. Roche Recent Developments
Table 29. Pfizer Basic Information List
Table 30. Pfizer Description and Business Overview
Table 31. Pfizer Targeted Drug ROS1 Inhibitors for NSCLC Products, Services and Solutions
Table 32. Revenue (US$ Million) in Targeted Drug ROS1 Inhibitors for NSCLC Business of Pfizer (2016-2021)
Table 33. Pfizer Recent Developments
Table 34. Beacon Pharma Limited Basic Information List
Table 35. Beacon Pharma Limited Description and Business Overview
Table 36. Beacon Pharma Limited Targeted Drug ROS1 Inhibitors for NSCLC Products, Services and Solutions
Table 37. Revenue (US$ Million) in Targeted Drug ROS1 Inhibitors for NSCLC Business of Beacon Pharma Limited (2016-2021)
Table 38. Beacon Pharma Limited Recent Developments
Table 39. Drug International Limted Basic Information List
Table 40. Drug International Limted Description and Business Overview
Table 41. Drug International Limted Targeted Drug ROS1 Inhibitors for NSCLC Products, Services and Solutions
Table 42. Revenue (US$ Million) in Targeted Drug ROS1 Inhibitors for NSCLC Business of Drug International Limted (2016-2021)
Table 43. Drug International Limted Recent Developments
Table 44. Incepta Pharmaceuticals Basic Information List
Table 45. Incepta Pharmaceuticals Description and Business Overview
Table 46. Incepta Pharmaceuticals Targeted Drug ROS1 Inhibitors for NSCLC Products, Services and Solutions
Table 47. Revenue (US$ Million) in Targeted Drug ROS1 Inhibitors for NSCLC Business of Incepta Pharmaceuticals (2016-2021)
Table 48. Incepta Pharmaceuticals Recent Developments
Table 49. North America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2016-2021) & (US$ Million)
Table 50. North America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2022-2027) & (US$ Million)
Table 51. Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2016-2021) & (US$ Million)
Table 52. Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Region (2016-2021) & (US$ Million)
Table 54. Asia-Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Region (2022-2027) & (US$ Million)
Table 55. Asia-Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Region (2016-2021)
Table 56. Asia-Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Region (2022-2027)
Table 57. Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Players (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2022-2027) & (US$ Million)
Table 61. Targeted Drug ROS1 Inhibitors for NSCLC Market Trends
Table 62. Targeted Drug ROS1 Inhibitors for NSCLC Market Drivers
Table 63. Targeted Drug ROS1 Inhibitors for NSCLC Market Challenges
Table 64. Targeted Drug ROS1 Inhibitors for NSCLC Market Restraints
Table 65. Research Programs/Design for This Report
Table 66. Key Data Information from Secondary Sources
Table 67. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size Year-over-Year 2016-2027 & (US$ Million)
Figure 2. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 3. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Regions: 2021 VS 2027
Figure 4. Global Targeted Drug ROS1 Inhibitors for NSCLC Forecasted Market Size Share by Region (2022-2027)
Figure 5. North America Targeted Drug ROS1 Inhibitors for NSCLC Market Size (US$ Million) Growth Rate (2016-2027)
Figure 6. Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 7. Asia-Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 8. Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 9. Middle East & Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 10. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size Share by Type in 2021 & 2027
Figure 11. Crizotinib Market Size (US$ Million) YoY Growth (2016-2027)
Figure 12. Lorlatinib Market Size (US$ Million) YoY Growth (2016-2027)
Figure 13. Entrectinib Market Size (US$ Million) YoY Growth (2016-2027)
Figure 14. Other Market Size (US$ Million) YoY Growth (2016-2027)
Figure 15. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size Share by Application in 2021 & 2027
Figure 16. Squamous Cell Carcinoma of NSCLC Market Size (US$ Million) YoY Growth (2016-2027)
Figure 17. Adenocarcinoma of NSCLC Market Size (US$ Million) YoY Growth (2016-2027)
Figure 18. Large Cell Carcinoma of NSCLC Market Size (US$ Million) YoY Growth (2016-2027)
Figure 19. Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 20. Global Top 5 and Top 10 Players Targeted Drug ROS1 Inhibitors for NSCLC Market Share in 2020
Figure 21. North America Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Country (2016-2027)
Figure 22. United States Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million)
Figure 23. Canada Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million)
Figure 24. Germany Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million)
Figure 25. France Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million)
Figure 26. U.K. Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million)
Figure 27. Italy Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million)
Figure 28. Russia Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million)
Figure 29. Nordic Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million)
Figure 30. Rest of Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million)
Figure 31. Asia-Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Region (2016-2027)
Figure 32. China Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million)
Figure 33. Japan Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million)
Figure 34. South Korea Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million)
Figure 35. Southeast Asia Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million)
Figure 36. India Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million)
Figure 37. Australia Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million)
Figure 38. Rest of Asia-Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million)
Figure 39. Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Country (2016-2027)
Figure 40. Mexico Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million)
Figure 41. Brazil Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million)
Figure 42. Rest of Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million)
Figure 43. Middle East & Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Country (2016-2027)
Figure 44. Turkey Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million)
Figure 45. Saudi Arabia Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million)
Figure 46. UAE Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million)
Figure 47. Rest of Middle East & Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Keyplayers in Global Targeted Drug ROS1 Inhibitors for NSCLC Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
RochePfizer
Beacon Pharma Limited
Drug International Limted
Incepta Pharmaceuticals
Request Sample
Request Discount
